Details for 2012156035
Up to date per 02.04.2026
Actions
Details for 2012156035
Granted/Registered
European Patent
23.05.2012 A
16.12.2020 B1
17.10.2008
US
106260 P
17.10.2008
US
106231 P
14.10.2009
US
578934
C07D 309/10 20060101AFI20120328BHEP
Owner
Janssen Pharmaceutica N.V.Turnhoutseweg 30 2340 BeerseBE
Mitsubishi Tanabe Pharma Corporation2-6-18, Kitahama Chuo-ku Osaka-shi Osaka 541-8505JP
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
Filliers, Walter Ferdinand Mariac/o Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 BeerseBE
Nieste, Patrick Hubert J.c/o Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 BeerseBE
Hatsuda, Masanoric/o Mitsubishi Tanabe Pharma Corporation 2-6-18, Kitahama Chuo-ku Osaka, 541-8505JP
Yoshinaga, Masahikoc/o Mitsubishi Tanabe Pharma Corporation 2-6-18, Kitahama Chuo-ku Osaka, 541-8505JP
Yada, Mitsuhiroc/o Mitsubishi Tanabe Pharma Corporation 2-6-18, Kitahama Chuo-ku Osaka, 541-8505JP
Teleha, Christopherc/o Johnson and Johnson Pharmaceutical R&D Welsh and McKean Roads Spring House, PA Pennsylvania 19477-0776US
Broeckx, Rudy Laurent Mariac/o Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 BeerseBE
Information about Fees